APHRANEL Global Launch Meeting, in Shanghai China
APHRANEL Global Launch Meeting: Code Breaker, World Maker
Technological Breakthrough: Precision Innovation, Redefining Industry Standards
Leveraging proprietary technology, MOYOM Biotechnology has precisely controlled calcium hydroxylapatite (CaHA) microsphere size (30-35μm), through-hole structure, and degradation rate, successfully developing the Aphranel MagiCCrystal CaHA Filler.
Corporate Vision: Innovation-Driven Leadership for Sustainable Development
"We are committed to providing safer and more accessible products for the global medical aesthetics market through technological innovation, and promoting the sustainable development of the industry," said the CEO of MOYOM Biotechnology.
About Aphranel
Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
View original content to download multimedia:https://www.prnewswire.com/news-releases/aphranel-global-launch-meeting-in-shanghai-china-302424657.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Consumers Energy Invests in Reliability Upgrades to Secure the Grid for Michigan Customers
- 5 Tax Moves Retirees Should Consider Before the End of 2026
- TROOPS, Inc. (NASDAQ: TROO) Issues Statement Rebutting Misleading Short-Seller Report and Provides Update on Hong Kong Legal Proceedings
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share